Patent · US Expired

Urea derivatives

US6001833A · kind A · utility

2Cited by

0References

5Claims

0Family size

Assignee

Solvay Pharmaceuticals, GmbH · US

Inventors

Daniel Jasserand · Paris, FR
Samuel David · Dorval, CA
Jochen Antel · Annaberg-Buchholz, DE
Reinhard Brueckner · Hannover, DE
Christian Eeckhout · Winsen (Aller), DE
Gerhard-Wilhelm Bielenberg · Alfeld (Leine), DE

Key dates

Filing date	Aug 27, 1998
Grant date	Dec 14, 1999
Priority date	—
Expiry date	Aug 27, 2018

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of Formula I ##STR1## wherein R.sup.1 is hydrogen or lower alkyl, PA1 R.sup.2 is hydrogen or halogen and PA1 R.sup.3 is hydrogen or lower alkoxy, and their pharmacologically acceptable acid addition salts and pharmaceutical compositions containing these compounds and also processes for the preparation of these compounds. Pharmaceutical composition containing these compounds are suitable, for example, for treating functional and inflammatory disorders of the gastrointestinal tract.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.